Endo International buy krebskrebs
Start price
21.02.22
/
50%
€2.62
Target price
21.02.23
€4.00
Performance (%)
-93.12%
End price
22.02.23
€0.18
Summary
This prediction ended on 22.02.23 with a price of €0.18. Massive losses of -93.12% were the result for the BUY prediction by krebskrebs. krebskrebs has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Endo International | - | - | - | - |
| iShares Core DAX® | -1.104% | -6.084% | 0.866% | 54.489% |
| iShares Nasdaq 100 | 0.328% | 2.327% | 18.263% | 85.552% |
| iShares Nikkei 225® | -1.082% | -7.987% | 26.339% | 55.407% |
| iShares S&P 500 | -0.055% | 0.880% | 13.287% | 62.988% |
Comments by krebskrebs for this prediction
In the thread Endo International diskutieren
Buy mit Kursziel 4,0
In the thread Trading Endo International
Die von krebskrebs gewählte maximale Laufzeit wurde überschritten

